First Page | Meta Content | |
---|---|---|
Document Date: 2014-10-01 21:56:22Open Document File Size: 82,80 KBShare Result on FacebookCityal Population / Study / /CompanyImmune Deficiency Syndromes / Immunodeficiency Syndrome / /CountryUnited States / Australia / /CurrencyUSD / /EntertainmentAwardEventthe OSCAR / /EventFDA Phase / /FacilityPublic Hospital / Private Hospital / /IndustryTermHIV Treatment / genotypic algorithms / treatment of HIV / antiretroviral medicinal products / geno2pheno algorithm / therapy for HIV / /MedicalConditionHIV / disease / Acquired Immunodeficiency Syndrome / Clinical Infectious Diseases / Infectious Diseases / infection / infectious disease / chronic conditions / /MedicalTreatmentantiretroviral therapy / HAART / alternative therapies / Antiviral Therapy / /OrganizationPrivate Hospital / Public Hospital / /PositionMajor / Trial ID/First Author / /Productefavirenz / Zidovudine / Lamivudine / Maraviroc / HIV-1 / A4001026 / /PublishedMediumThe Journal of Infectious Diseases / Journal of Acquired Immune Deficiency Syndromes / Antiviral Therapy / Clinical Infectious Diseases / Journal of Clinical Microbiology / /Technologybioinformatics / geno2pheno algorithm / Chemotherapy / genotyping / genotype / /SocialTag |